New drug PALI-2108 studied for Crohn's scarring
Knowledge-focused
Ongoing
This study tests an experimental drug called PALI-2108 in 6 adults with fibrostenotic Crohn's disease, a condition where the gut becomes scarred and narrow. Participants take the drug for 14 days, and researchers analyze tissue samples to see how it affects inflammation and scarr…
Phase: PHASE1 • Sponsor: Palisade Bio • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:35 UTC